Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repisalud
Publication Artículo científico (JournalArticle)

Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive Aspergillosis

  • Lupiañez, Carmen B
  • Villaescusa, María T
  • Carvalho, Agostinho
  • Springer, Jan
  • Lackner, Michaela
  • Sánchez-Maldonado, Jose Manuel
  • Canet, Luz M
  • Cunha, Cristina
  • Segura-Catena, Juana
  • Alcazar-Fuoli, Laura
  • Solano, Carlos
  • Fianchi, Luana
  • Pagano, Livio
  • Potenza, Leonardo
  • Aguado, José María
  • Luppi, Mario
  • Cuenca-Estrella, Manuel
  • Lass-Flörl, Cornelia
  • Einsele, Hermann
  • Vázquez, Lourdes
  • Ríos-Tamayo, Rafael
  • Loeffler, Jurgen
  • Jurado, Manuel
  • Sainz, Juan
Invasive Aspergillosis (IA) is an opportunistic infection caused by Aspergillus, a ubiquitously present airborne pathogenic mold. A growing number of studies suggest a major host genetic component in disease susceptibility. Here, we evaluated whether 14 single-nucleotide polymorphisms within NFκB1, NFκB2, RelA, RelB, Rel, and IRF4 genes influence the risk of IA in a population of 834 high-risk patients (157 IA and 677 non-IA) recruited through a collaborative effort involving the aspBIOmics consortium and four European clinical institutions. No significant overall associations between selected SNPs and the risk of IA were found in this large cohort. Although a hematopoietic stem cell transplantation (HSCT)-stratified analysis revealed that carriers of the IRF4 rs12203592T/T genotype had a six-fold increased risk of developing the infection when compared with those carrying the C allele (ORREC = 6.24, 95%CI 1.25-31.2, P = 0.026), the association of this variant with IA risk did not reach significance at experiment-wide significant threshold. In addition, we found an association of the IRF4AATC and IRF4GGTC haplotypes (not including the IRF4 rs12203592T risk allele) with a decreased risk of IA but the magnitude of the association was similar to the one observed in the single-SNP analysis, which indicated that the haplotypic effect on IA risk was likely due to the IRF4 rs12203592 SNP. Finally, no evidence of significant interactions among the genetic markers tested and the risk of IA was found. These results suggest that the SNPs on the studied genes do not have a clinically relevant impact on the risk of developing IA.
Docta Complutense
Publication Artículo científico (JournalArticle)

Determinants of HIV-1 Late Presentation in Patients Followed in Europe.

  • Miranda, Mafalda N. S.
  • Pingarilho, Marta
  • Pimentel, Victor
  • Martins, Maria do Rosário O.
  • Vandamme, Anne-Mieke
  • Bobkova, Marina
  • Böhm, Michael
  • Seguin-Devaux, Carole
  • Paredes, Roger
  • Zazzi, Maurizio
  • Rubio García, Rafael
  • Incardona, Francesca
  • Abecasis, Ana
To control the Human Immunodeficiency Virus (HIV) pandemic, the World Health Organization (WHO) set the 90-90-90 target to be reached by 2020. One major threat to those goals is late presentation, which is defined as an individual presenting a TCD4+ count lower than 350 cells/mm3 or an AIDS-defining event. The present study aims to identify determinants of late presentation in Europe based on the EuResist database with HIV-1 infected patients followed-up between 1981 and 2019. Our study includes clinical and socio-demographic information from 89851 HIV-1 infected patients. Statistical analysis was performed using RStudio and SPSS and a Bayesian network was constructed with the WEKA software to analyze the association between all variables. Among 89,851 HIV-1 infected patients included in the analysis, the median age was 33 (IQR: 27.0–41.0) years and 74.4% were males. Of those, 28,889 patients (50.4%) were late presenters. Older patients (>56), heterosexuals, patients originated from Africa and patients presenting with log VL >4.1 had a higher probability of being late presenters (p < 0.001). Bayesian networks indicated VL, mode of transmission, age and recentness of infection as variables that were directly associated with LP. This study highlights the major determinants associated with late presentation in Europe. This study helps to direct prevention measures for this population.